Katie Rosengrant, RAC-Drugs has experience in regulatory affairs, project management, and operations for early-stage biotech companies. Her background includes contributions to IND submissions as well as coordination of grant applications, reporting requirements, and other cross-functional deliverables in oncology, infectious disease, and rare disease.